New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Read moreFoodborne Illness
Few people with peanut allergy tolerate peanut after stopping oral immunotherapy
Studies have shown that peanut oral immunotherapy (OIT) — ingesting small, controlled amounts of peanut protein — can desensitize adults and children and prevent allergic reactions, but the optimal duration and dose is unknown. In a study that followed participants after successful OIT, discontinuing OIT or continuing OIT at a reduced dose led to a decline in its protective effects. The study also found that blood tests administered before OIT could predict the success of therapy.
Read more